|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-02-04 | AbbVie : Merck says hepatitis C drugs to lose breakthrough status | RE |
| 14-06-10 | Apple : Wall St. edges up, lifted by mergers, acquisitions | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -0.61% | -3.43% | -0.57% | -5.85% | +6.34% | +36.07% | +115.04% | +408.27% | +1,309.01% | 1,019B | |
| -1.02% | -5.60% | -6.98% | -2.66% | +23.72% | +35.72% | +64.63% | +60.80% | +115.48% | 617B | |
| +1.11% | -0.58% | +2.48% | +0.67% | +15.02% | +12.36% | +77.95% | +141.72% | +317.17% | 464B | |
| +0.34% | -3.01% | -4.01% | +11.38% | +37.09% | +61.79% | +41.24% | +73.65% | +131.03% | 356B | |
| +1.27% | -1.21% | -0.71% | +5.82% | +6.98% | +21.74% | +42.32% | +1.34% | +45.87% | 333B | |
| +1.21% | -2.83% | -5.98% | -5.71% | +7.63% | +11.49% | +35.23% | +55.21% | +52.80% | 267B | |
| +0.49% | -4.35% | -0.77% | -15.26% | -13.35% | -6.11% | +9.60% | +34.92% | +136.99% | 244B | |
| -1.04% | -2.79% | -7.82% | +7.72% | +23.14% | +35.30% | +51.84% | +90.62% | +140.55% | 218B | |
| -1.87% | -4.10% | -4.14% | +10.26% | +17.92% | +28.44% | +93.66% | +114.24% | +87.39% | 179B | |
| -1.12% | -2.32% | -17.58% | -23.26% | -24.24% | -36.26% | -61.25% | -21.34% | +77.46% | 166B | |
| -1.14% | -3.03% | -2.28% | +14.31% | +11.65% | +1.57% | -16.54% | -34.46% | -17.56% | 158B | |
| -0.40% | -4.08% | -7.58% | -4.41% | +11.33% | +25.15% | +43.00% | +184.52% | +484.04% | 128B | |
| -0.50% | -2.72% | -8.49% | +5.20% | +13.37% | +34.54% | +7.79% | +3.77% | +10.76% | 125B | |
| +0.38% | +4.11% | -0.63% | +14.75% | +10.00% | +22.25% | +104.12% | +351.23% | +444.66% | 105B | |
| +1.12% | -0.51% | -5.36% | -3.87% | -13.41% | -16.50% | -30.36% | -14.17% | +4.20% | 95.48B | |
| +0.17% | -3.98% | -2.80% | -9.93% | -2.11% | +10.52% | +20.43% | +2.94% | -15.41% | 94.34B | |
| +0.57% | -4.46% | +30.55% | +138.23% | +544.32% | +566.94% | +82.25% | -41.69% | - | 75.86B | |
| +0.05% | -6.71% | -11.18% | +12.37% | -4.75% | +22.53% | -9.79% | +32.37% | +85.10% | 73.41B | |
| -0.16% | -1.16% | +1.30% | -4.17% | +11.62% | +13.85% | -11.45% | -26.58% | +42.48% | 66.99B | |
| Average | -0.13% | -2.86% | -2.77% | +7.66% | +35.91% | +46.39% | +34.72% | +74.60% | +191.78% | 239.28B | |
| Weighted average by Cap. | -0.06% | -3.24% | -2.96% | +1.43% | +19.41% | +32.86% | +56.49% | +137.45% | +389.81% |
- Stock Market
- Stocks
- Stock
- Sector Idenix Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
